These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2173542)

  • 1. Glucose and physostigmine effects on morphine- and amphetamine-induced increases in locomotor activity in mice.
    Stone WS; Rudd RJ; Gold PE
    Behav Neural Biol; 1990 Sep; 54(2):146-55. PubMed ID: 2173542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists.
    Stone WS; Walser B; Gold SD; Gold PE
    Behav Neurosci; 1991 Apr; 105(2):264-71. PubMed ID: 2043273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose and brain function: interactions with CNS cholinergic systems.
    Stone WS; Cottrill KL; Walker DL; Gold PE
    Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of physostigmine on the conditioned hyperactivity and locomotor sensitization to morphine in rats.
    Li X; Li JX; Zhu X; Cui R; Jiao J
    Behav Brain Res; 2010 Jan; 206(2):223-8. PubMed ID: 19761800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice.
    Medina Jiménez M; Luján Estrada M; Rodríguez R
    Arch Med Res; 1997; 28(1):61-5. PubMed ID: 9078589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists.
    Walker DL; McGlynn T; Grey C; Ragozzino M; Gold PE
    Psychopharmacology (Berl); 1991; 105(1):57-62. PubMed ID: 1745712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-induced deficits in sleep patterns: attenuation by glucose.
    Arankowsky-Sandoval G; Gold PE
    Neurobiol Learn Mem; 1995 Sep; 64(2):133-8. PubMed ID: 7582821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of humoral modulators of morphine-induced increase in locomotor activity of mice.
    Oka T; Hosoya E
    Jpn J Pharmacol; 1976 Oct; 26(5):615-9. PubMed ID: 137340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    Shannon HE; Peters SC
    J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic manipulations in the rat basolateral amygdaloid nucleus on locomotor activity induced by amphetamine.
    Gómez MN; Campos HA
    Brain Res; 1987 Feb; 404(1-2):304-6. PubMed ID: 3567573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse.
    Stevens KE; Mickley GA; McDermott LJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1739-47. PubMed ID: 3737639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of nigral dopamine neurons to actue and prolonged morphine treatment: effect of exposure to cold, physostigmine and nicotine.
    Lienhart R; Lichtensteiger W; Langemann H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 286(4):353-69. PubMed ID: 1143352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors.
    Grung M; Skurtveit S; Aasmundstad TA; Handal M; Alkana RL; Mørland J
    Pharmacol Toxicol; 1998 Jan; 82(1):3-10. PubMed ID: 9527644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia.
    Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A
    J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
    Ranaldi R; Munn E; Neklesa T; Wise RA
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of localized lesions of n. accumbens on morphine- and amphetamine-induced locomotor hyperactivity in the C57BL/6J mouse.
    Teitelbaum H; Giammatteo P; Mickley GA
    J Comp Physiol Psychol; 1979 Aug; 93(4):745-51. PubMed ID: 479406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential attenuation by atropine and d-amphetamine on hyperactivity: possible clinical implications.
    Egbe PC; Wray SR
    Psychopharmacology (Berl); 1977 Aug; 54(1):25-30. PubMed ID: 410057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors.
    Jones DN; Holtzman SG
    J Pharmacol Exp Ther; 1992 Aug; 262(2):638-45. PubMed ID: 1323656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.